PCI术后常见问题的中医治疗研究进展
Research Progress in Traditional Chinese Medicine Treatment for Common Problems after PCI
摘要: 经皮冠状动脉介入治疗(PCI)是冠心病治疗的核心手段,但术后常并发心绞痛、造影剂肾病(CIN)及焦虑抑郁等问题,严重影响患者预后及生活质量。中医药凭借多靶点、整体调节的优势,在改善PCI术后并发症中展现出独特潜力。本文系统综述近年来中医对PCI术后常见问题的认识与治疗进展:1. 针对术后心绞痛,中医以“胸痹”“真心痛”为纲,遵循“阳微阴弦”病机,提出益气通络、活血化瘀、调畅气机等治法,临床研究证实其取得了良好的治疗效果;2. 针对CIN,中医立足“毒瘀互结”理论,采用解毒化瘀、调和脏腑等法,如川黄汤、八珍汤等,可有效改善肾功能;3. 针对术后焦虑抑郁,中医以“双心医学”为框架,结合疏肝解郁、养心安神等辨证论治策略,配合针灸、八段锦等非药物疗法,疗效优于单纯西药且安全性更佳。现有研究表明,中医药可有效改善PCI术后病理状态,但亟需构建规范化的诊疗体系及循证医学证据以提升临床转化价值。未来研究需进一步整合辨证论治与现代医学模式,优化疗效评价标准,为降低PCI术后并发症提供中西医结合新思路。
Abstract: Percutaneous coronary intervention (PCI) is a core treatment for coronary heart disease, but it is often complicated by post-operative angina pectoris, contrast-induced nephropathy (CIN), anxiety, and depression, which severely affect patients’ prognosis and quality of life. Traditional Chinese medicine (TCM), leveraging its advantages of multi-target regulation and holistic intervention, has demonstrated unique potential in improving post-PCI complications. This paper systematically reviews recent TCM insights and treatment advances for common post-PCI issues: 1. For post-operative angina pectoris, TCM classifies it under “chest bi” (chest obstruction) and “true heart pain,” following the pathogenesis of “yang deficiency and yin excess.” Therapeutic strategies such as replenishing qi to dredge collaterals, activating blood circulation to remove stasis, and regulating qi movement have been proposed. Clinical studies have confirmed that these approaches yield favorable therapeutic effects. 2. For CIN, based on the TCM theory of “toxicity-stasis interconnection,” methods such as detoxifying to resolve stasis and harmonizing zang-fu organs (e.g., Chuanhuang Decoction, Bazhen Decoction) are used, which can effectively improve renal function. 3. For post-operative anxiety and depression, TCM adopts the “dual heart medicine” framework, combining syndrome differentiation strategies like soothing the liver to relieve depression and nourishing the heart to calm the mind, alongside non-pharmacological therapies such as acupuncture and Baduanjin. These interventions show better efficacy and safety compared to Western medicine alone. Existing research indicates that TCM can effectively improve post-PCI pathological states, but there is an urgent need to establish standardized diagnostic and treatment systems and evidence-based medical evidence to enhance clinical translation value. Future studies should further integrate syndrome differentiation with modern medical models, optimize efficacy evaluation criteria, and provide new integrative approaches for reducing post-PCI complications.
文章引用:付德智, 何昱飞, 张灵, 杨蓝蓝. PCI术后常见问题的中医治疗研究进展[J]. 中医学, 2025, 14(6): 2533-2538. https://doi.org/10.12677/tcm.2025.146373

参考文献

[1] Zhong, Y.L., Ma, W.G., Zhu, J.M., et al. (2020) Surgical Repair of Cervical Aortic arch: An Alternative Classification Scheme Based on Experience in 35 Patients. The Journal of Thoracic and Cardiovascular Surgery, 159, 2202-2213.E4. [Google Scholar] [CrossRef] [PubMed]
[2] 吴兴舟. 心血管病行冠脉介入性治疗的作用[J]. 中国实用医药, 2019, 14(11): 3-5.
[3] Crea, F., Bairey Merz, C.N., Beltrame, J.F., et al. (2019) Mechanisms and Diagnostic Evaluation of Persistent or Recurrent Angina Following Percutaneous Coronary Revascularization. European Heart Journal, 40, 2455-2462. [Google Scholar] [CrossRef] [PubMed]
[4] 谢蓓莉. 赵福海教授治疗PCI术后心绞痛的用药规律分析及网络药理学研究[D]: [硕士学位论文]. 北京: 中国中医科学院, 2022.
[5] Isaka, Y., Hayashi, H., Aonuma, K., et al. (2020) Guideline on the Use of Iodinated Contrast Media in Patients with Kidney Disease 2018. Japanese Journal of Radiology, 38, 3-46. [Google Scholar] [CrossRef] [PubMed]
[6] 余雅, 杨定平, 卢远航, 易晔. 经皮冠状动脉介入术后造影剂肾病的发生率及危险因素分析[J]. 医学综述, 2021, 27(18): 3706-3710.
[7] 曾淑媛, 邓春友, 谢艳群, 宏峰, 黄秀霞. 强化静脉水化疗法对冠脉造影及介入治疗并发造影剂肾病的作用分析[J]. 包头医学, 2021, 45(2): 45-47.
[8] 欧阳海春, 麦思资, 夏风帆, 等. 急性心肌梗死直接PCI术后抑郁和焦虑的临床跟踪研究[J]. 心理月刊, 2020(23): 62-63, 95.
[9] Damen, N.L., Versteeg, H., Boersma, E., Serruys, P.W., van Geuns, R.M., Denollet, J., et al. (2013) Depression Is Independently Associated with 7-Year Mortality in Patients Treated with Percutaneous Coronary Intervention: Results from the RESEARCH Registry. International Journal of Cardiology, 167, 2496-2501. [Google Scholar] [CrossRef] [PubMed]
[10] 李玉莹, 李佳玲, 罗莉, 黄浩洋, 李雅, 郭志华. 双心疾病的中西医研究进展[J]. 湖南中医杂志, 2020, 36(6): 148-149.
[11] 李舒钰, 赵明君. 赵明君教授基于络病理论治疗PCI术后心绞痛经验[J]. 中西医结合研究, 2022, 14(5): 341-343+347.
[12] 赵凡莹. 黄丽娟教授治疗冠心病PCI术后再发心绞痛的用药规律研究[D]: [硕士学位论文]. 北京: 北京中医药大学, 2020.
[13] 高帅, 樊瑞红. 从心肾相交理论探讨冠脉介入术后再发心绞痛的中医药治疗[J]. 中国中医药现代远程教育, 2020, 18(24): 116-118.
[14] 龚学忠. 从“毒瘀互结”论治造影剂肾病[J]. 上海中医药杂志, 2012, 46(2): 57-59.
[15] 王东芳, 杨国华. “和法”在急诊PCI术后造影剂肾病治疗中的应用探析[J]. 中国中医急症, 2018, 27(7): 1310-1313.
[16] 王东芳. 急诊PCI术后造影剂肾病的证素特征及八珍汤的疗效评价研究[D]: [博士学位论文]. 北京: 中国中医科学院, 2018.
[17] 胡大一. 心血管疾病和精神心理障碍的综合管理——“双心医学”模式的探索[J]. 中国临床医生, 2006, 34(5): 2-3.
[18] 武婧, 张学婷, 袁果真, 崔向宁. 从调畅肝气论治“双心疾病” [J]. 中华中医药杂志, 2018, 33(9): 3958-3961.
[19] 肖珉, 常佩芬, 赵勇, 谢文芳, 朱海燕, 王亚红. 郭维琴教授治疗心血管疾病合并焦虑症的临床经验[J]. 现代中医临床, 2016, 23(5): 17-20.
[20] 张恩圆, 刘园园, 吴雪, 王诚建, 司海龙. 芪参益气滴丸在冠心病支架置入术后合并抑郁及焦虑患者中的应用[J]. 中国心血管病研究, 2022, 20(11): 978-983.
[21] 高建步, 李玉东, 杨守忠, 闻公灵, 崔爽. 益心舒胶囊对经皮冠状动脉介入术后患者生活质量和焦虑、抑郁情绪的影响[J]. 中国新药杂志, 2017, 26(10): 1148-1151.
[22] 杨婧, 周旭升, 张捷. 浅谈针灸在双心医学中的应用[J]. 时珍国医国药, 2015, 26(2): 421-422.
[23] 孙晓静, 张剑梅, 王立中, 张振英, 张柳, 冯静. 八段锦联合有氧踏车对PCI术后患者焦虑、抑郁及心肺功能的影响[J]. 中国体育科技, 2020, 56(5): 41-47.
[24] 周华东, 龙贤, 孔德娇, 张竣玮, 顾健霞. 中医药治疗PCI术后焦虑抑郁状态疗效的Meta分析[J]. 中医药临床杂志, 2021, 33(3): 455-461.